Structure

Physi-Chem Properties

Molecular Weight:  572.42
Volume:  642.313
LogP:  7.975
LogD:  5.89
LogS:  -6.811
# Rotatable Bonds:  4
TPSA:  46.53
# H-Bond Aceptor:  3
# H-Bond Donor:  1
# Rings:  6
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.223
Synthetic Accessibility Score:  4.873
Fsp3:  0.718
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.255
MDCK Permeability:  1.8948861907119863e-05
Pgp-inhibitor:  0.954
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.672
30% Bioavailability (F30%):  0.96

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.072
Plasma Protein Binding (PPB):  100.86975860595703%
Volume Distribution (VD):  1.614
Pgp-substrate:  2.1659505367279053%

ADMET: Metabolism

CYP1A2-inhibitor:  0.028
CYP1A2-substrate:  0.398
CYP2C19-inhibitor:  0.174
CYP2C19-substrate:  0.921
CYP2C9-inhibitor:  0.081
CYP2C9-substrate:  0.964
CYP2D6-inhibitor:  0.419
CYP2D6-substrate:  0.812
CYP3A4-inhibitor:  0.27
CYP3A4-substrate:  0.425

ADMET: Excretion

Clearance (CL):  4.819
Half-life (T1/2):  0.105

ADMET: Toxicity

hERG Blockers:  0.222
Human Hepatotoxicity (H-HT):  0.248
Drug-inuced Liver Injury (DILI):  0.025
AMES Toxicity:  0.002
Rat Oral Acute Toxicity:  0.027
Maximum Recommended Daily Dose:  0.941
Skin Sensitization:  0.959
Carcinogencity:  0.007
Eye Corrosion:  0.045
Eye Irritation:  0.609
Respiratory Toxicity:  0.752

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC86257

Natural Product ID:  NPC86257
Common Name*:   3-Alpha-Z-Coumaroyltaraxerol
IUPAC Name:   [(3R,4aR,6aR,6aS,8aR,12aR,14aR,14bR)-4,4,6a,6a,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl] (Z)-3-(4-hydroxyphenyl)prop-2-enoate
Synonyms:  
Standard InCHIKey:  FZPSABBXYRSWMG-SYLDJCCYSA-N
Standard InCHI:  InChI=1S/C39H56O3/c1-34(2)23-24-36(5)19-15-29-38(7)20-16-28-35(3,4)32(42-33(41)14-11-26-9-12-27(40)13-10-26)18-22-37(28,6)30(38)17-21-39(29,8)31(36)25-34/h9-15,28,30-32,40H,16-25H2,1-8H3/b14-11-/t28-,30+,31+,32+,36-,37-,38-,39+/m0/s1
SMILES:  CC1(C)CC[C@]2(C)CC=C3[C@]4(C)CC[C@H]5C(C)(C)[C@@H](CC[C@]5(C)[C@H]4CC[C@@]3(C)[C@@H]2C1)OC(=O)/C=Cc1ccc(cc1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL452896
PubChem CID:   10076796
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001552] Sesterterpenoids
          • [CHEMONTID:0002883] Scalarane sesterterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO10036 Bruguiera cylindrica Species Rhizophoraceae Eukaryota Fruits n.a. n.a. PMID[15165157]
NPO10036 Bruguiera cylindrica Species Rhizophoraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT639 Cell Line NCI-H187 Homo sapiens IC50 = 20.0 ug.mL-1 PMID[492831]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC86257 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9531 High Similarity NPC477874
0.9531 High Similarity NPC173569
0.9457 High Similarity NPC249817
0.9453 High Similarity NPC11266
0.9385 High Similarity NPC475482
0.9385 High Similarity NPC216940
0.9385 High Similarity NPC22676
0.9385 High Similarity NPC198621
0.9313 High Similarity NPC182249
0.9274 High Similarity NPC265413
0.9274 High Similarity NPC10154
0.9242 High Similarity NPC271494
0.9242 High Similarity NPC155192
0.9242 High Similarity NPC473591
0.9173 High Similarity NPC27518
0.9173 High Similarity NPC304110
0.9173 High Similarity NPC172311
0.9167 High Similarity NPC139243
0.9167 High Similarity NPC248287
0.9167 High Similarity NPC116742
0.9167 High Similarity NPC234548
0.9098 High Similarity NPC470616
0.9098 High Similarity NPC470617
0.9077 High Similarity NPC475627
0.9077 High Similarity NPC475346
0.9077 High Similarity NPC475457
0.9077 High Similarity NPC18982
0.9037 High Similarity NPC477873
0.9037 High Similarity NPC469447
0.903 High Similarity NPC473612
0.903 High Similarity NPC472801
0.8971 High Similarity NPC25491
0.8968 High Similarity NPC474532
0.8963 High Similarity NPC35212
0.896 High Similarity NPC478058
0.8905 High Similarity NPC307205
0.8905 High Similarity NPC53520
0.8897 High Similarity NPC252133
0.8897 High Similarity NPC310621
0.8897 High Similarity NPC235557
0.8832 High Similarity NPC26045
0.8769 High Similarity NPC288290
0.875 High Similarity NPC137416
0.8714 High Similarity NPC477483
0.8714 High Similarity NPC325032
0.8705 High Similarity NPC8102
0.8705 High Similarity NPC66894
0.8657 High Similarity NPC472804
0.8592 High Similarity NPC327962
0.8582 High Similarity NPC194970
0.8531 High Similarity NPC118033
0.8529 High Similarity NPC471152
0.8521 High Similarity NPC279442
0.8472 Intermediate Similarity NPC473773
0.8472 Intermediate Similarity NPC475579
0.8462 Intermediate Similarity NPC145527
0.8462 Intermediate Similarity NPC470619
0.8462 Intermediate Similarity NPC208785
0.8462 Intermediate Similarity NPC470618
0.8443 Intermediate Similarity NPC139946
0.8403 Intermediate Similarity NPC475454
0.8403 Intermediate Similarity NPC475311
0.8403 Intermediate Similarity NPC473680
0.8403 Intermediate Similarity NPC473579
0.8382 Intermediate Similarity NPC43353
0.8369 Intermediate Similarity NPC235195
0.8369 Intermediate Similarity NPC19862
0.8369 Intermediate Similarity NPC280717
0.8369 Intermediate Similarity NPC271607
0.8357 Intermediate Similarity NPC204644
0.8333 Intermediate Similarity NPC76032
0.8333 Intermediate Similarity NPC132723
0.8322 Intermediate Similarity NPC96930
0.8322 Intermediate Similarity NPC32017
0.8288 Intermediate Similarity NPC205392
0.8288 Intermediate Similarity NPC105942
0.8281 Intermediate Similarity NPC135467
0.8281 Intermediate Similarity NPC260832
0.8273 Intermediate Similarity NPC471875
0.8264 Intermediate Similarity NPC298647
0.8264 Intermediate Similarity NPC292206
0.8264 Intermediate Similarity NPC473719
0.8264 Intermediate Similarity NPC273358
0.8258 Intermediate Similarity NPC473220
0.8258 Intermediate Similarity NPC470753
0.8209 Intermediate Similarity NPC30174
0.8209 Intermediate Similarity NPC131684
0.8203 Intermediate Similarity NPC93071
0.8203 Intermediate Similarity NPC126002
0.8189 Intermediate Similarity NPC122117
0.8188 Intermediate Similarity NPC476699
0.8182 Intermediate Similarity NPC470765
0.8182 Intermediate Similarity NPC320734
0.8176 Intermediate Similarity NPC472807
0.8169 Intermediate Similarity NPC96447
0.812 Intermediate Similarity NPC171007
0.812 Intermediate Similarity NPC190849
0.8116 Intermediate Similarity NPC279463
0.8088 Intermediate Similarity NPC18798
0.808 Intermediate Similarity NPC228425
0.8065 Intermediate Similarity NPC183700
0.8062 Intermediate Similarity NPC42657
0.8047 Intermediate Similarity NPC477136
0.8031 Intermediate Similarity NPC147179
0.8029 Intermediate Similarity NPC165612
0.8028 Intermediate Similarity NPC20631
0.8028 Intermediate Similarity NPC93640
0.8015 Intermediate Similarity NPC249425
0.8 Intermediate Similarity NPC176590
0.8 Intermediate Similarity NPC472938
0.8 Intermediate Similarity NPC472937
0.8 Intermediate Similarity NPC472936
0.8 Intermediate Similarity NPC477208
0.7984 Intermediate Similarity NPC471954
0.7984 Intermediate Similarity NPC75272
0.7972 Intermediate Similarity NPC477209
0.7971 Intermediate Similarity NPC476282
0.7969 Intermediate Similarity NPC470820
0.7969 Intermediate Similarity NPC308828
0.7969 Intermediate Similarity NPC219112
0.7969 Intermediate Similarity NPC477137
0.7969 Intermediate Similarity NPC308311
0.7969 Intermediate Similarity NPC38893
0.7969 Intermediate Similarity NPC471668
0.7967 Intermediate Similarity NPC260952
0.7959 Intermediate Similarity NPC162569
0.7959 Intermediate Similarity NPC35160
0.7958 Intermediate Similarity NPC138149
0.7956 Intermediate Similarity NPC153019
0.7955 Intermediate Similarity NPC121168
0.7953 Intermediate Similarity NPC268160
0.7953 Intermediate Similarity NPC41851
0.7941 Intermediate Similarity NPC117899
0.7939 Intermediate Similarity NPC470848
0.7939 Intermediate Similarity NPC470849
0.7917 Intermediate Similarity NPC474599
0.7917 Intermediate Similarity NPC477207
0.7917 Intermediate Similarity NPC471876
0.791 Intermediate Similarity NPC275576
0.7908 Intermediate Similarity NPC266365
0.7905 Intermediate Similarity NPC77310
0.7903 Intermediate Similarity NPC470039
0.7903 Intermediate Similarity NPC206341
0.7899 Intermediate Similarity NPC321086
0.7899 Intermediate Similarity NPC289624
0.7899 Intermediate Similarity NPC27578
0.7895 Intermediate Similarity NPC12824
0.7895 Intermediate Similarity NPC472373
0.7891 Intermediate Similarity NPC35797
0.7891 Intermediate Similarity NPC477206
0.7891 Intermediate Similarity NPC192948
0.7887 Intermediate Similarity NPC106055
0.7887 Intermediate Similarity NPC79372
0.7887 Intermediate Similarity NPC164743
0.7887 Intermediate Similarity NPC110699
0.7883 Intermediate Similarity NPC472793
0.7879 Intermediate Similarity NPC249340
0.7879 Intermediate Similarity NPC162935
0.7872 Intermediate Similarity NPC306365
0.7868 Intermediate Similarity NPC47288
0.7868 Intermediate Similarity NPC229894
0.7868 Intermediate Similarity NPC193203
0.7862 Intermediate Similarity NPC43716
0.7862 Intermediate Similarity NPC101255
0.7862 Intermediate Similarity NPC475719
0.7857 Intermediate Similarity NPC35630
0.7852 Intermediate Similarity NPC35341
0.7852 Intermediate Similarity NPC71610
0.7852 Intermediate Similarity NPC283508
0.7852 Intermediate Similarity NPC169913
0.7852 Intermediate Similarity NPC48671
0.7846 Intermediate Similarity NPC471671
0.7846 Intermediate Similarity NPC164649
0.7846 Intermediate Similarity NPC203124
0.7846 Intermediate Similarity NPC48342
0.7846 Intermediate Similarity NPC309434
0.7846 Intermediate Similarity NPC469609
0.7843 Intermediate Similarity NPC269668
0.7842 Intermediate Similarity NPC185777
0.7842 Intermediate Similarity NPC49742
0.7842 Intermediate Similarity NPC211352
0.7842 Intermediate Similarity NPC203486
0.7838 Intermediate Similarity NPC472939
0.7838 Intermediate Similarity NPC87630
0.7838 Intermediate Similarity NPC116292
0.7838 Intermediate Similarity NPC267469
0.7838 Intermediate Similarity NPC179128
0.7832 Intermediate Similarity NPC470035
0.7829 Intermediate Similarity NPC137496
0.7829 Intermediate Similarity NPC154511
0.7829 Intermediate Similarity NPC471936
0.7829 Intermediate Similarity NPC469663
0.7829 Intermediate Similarity NPC92
0.7829 Intermediate Similarity NPC247858
0.7829 Intermediate Similarity NPC474358
0.7829 Intermediate Similarity NPC257540
0.7829 Intermediate Similarity NPC474387
0.7826 Intermediate Similarity NPC473047
0.7826 Intermediate Similarity NPC243305
0.782 Intermediate Similarity NPC71094

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC86257 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8824 High Similarity NPD8166 Discontinued
0.8333 Intermediate Similarity NPD5736 Approved
0.8088 Intermediate Similarity NPD6663 Approved
0.8028 Intermediate Similarity NPD7003 Approved
0.7899 Intermediate Similarity NPD4140 Approved
0.7846 Intermediate Similarity NPD3091 Approved
0.7755 Intermediate Similarity NPD6273 Approved
0.7727 Intermediate Similarity NPD4626 Approved
0.7718 Intermediate Similarity NPD7458 Discontinued
0.7652 Intermediate Similarity NPD5691 Approved
0.7612 Intermediate Similarity NPD3092 Approved
0.7594 Intermediate Similarity NPD3019 Approved
0.7594 Intermediate Similarity NPD2932 Approved
0.7518 Intermediate Similarity NPD4060 Phase 1
0.75 Intermediate Similarity NPD5327 Phase 3
0.7483 Intermediate Similarity NPD7097 Phase 1
0.7463 Intermediate Similarity NPD3095 Discontinued
0.7452 Intermediate Similarity NPD8127 Discontinued
0.7447 Intermediate Similarity NPD8032 Phase 2
0.7398 Intermediate Similarity NPD3020 Approved
0.7391 Intermediate Similarity NPD3094 Phase 2
0.7343 Intermediate Similarity NPD5735 Approved
0.7333 Intermediate Similarity NPD4059 Approved
0.7329 Intermediate Similarity NPD7266 Discontinued
0.7323 Intermediate Similarity NPD3134 Approved
0.7305 Intermediate Similarity NPD7095 Approved
0.7305 Intermediate Similarity NPD7008 Discontinued
0.7297 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD6353 Approved
0.7273 Intermediate Similarity NPD3620 Phase 2
0.7273 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7254 Intermediate Similarity NPD3764 Approved
0.7218 Intermediate Similarity NPD4198 Discontinued
0.7214 Intermediate Similarity NPD4624 Approved
0.7213 Intermediate Similarity NPD1432 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD7236 Approved
0.7194 Intermediate Similarity NPD1283 Approved
0.7181 Intermediate Similarity NPD4628 Phase 3
0.7154 Intermediate Similarity NPD2860 Approved
0.7154 Intermediate Similarity NPD2859 Approved
0.7153 Intermediate Similarity NPD3496 Discontinued
0.7143 Intermediate Similarity NPD5406 Approved
0.7143 Intermediate Similarity NPD5408 Approved
0.7143 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD2797 Approved
0.7143 Intermediate Similarity NPD5405 Approved
0.7143 Intermediate Similarity NPD5404 Approved
0.7133 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7122 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD5535 Approved
0.7121 Intermediate Similarity NPD7635 Approved
0.7113 Intermediate Similarity NPD4908 Phase 1
0.7105 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD7446 Clinical (unspecified phase)
0.7103 Intermediate Similarity NPD6355 Discontinued
0.7095 Intermediate Similarity NPD5762 Approved
0.7095 Intermediate Similarity NPD5763 Approved
0.7092 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD7768 Phase 2
0.7075 Intermediate Similarity NPD7742 Approved
0.7075 Intermediate Similarity NPD7743 Approved
0.7073 Intermediate Similarity NPD2934 Approved
0.7073 Intermediate Similarity NPD2933 Approved
0.7068 Intermediate Similarity NPD4869 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD7741 Discontinued
0.7059 Intermediate Similarity NPD9545 Approved
0.7055 Intermediate Similarity NPD4097 Suspended
0.7055 Intermediate Similarity NPD4579 Clinical (unspecified phase)
0.7042 Intermediate Similarity NPD2861 Phase 2
0.7029 Intermediate Similarity NPD3023 Approved
0.7029 Intermediate Similarity NPD3026 Approved
0.7027 Intermediate Similarity NPD2935 Discontinued
0.7023 Intermediate Similarity NPD3022 Approved
0.7023 Intermediate Similarity NPD3021 Approved
0.702 Intermediate Similarity NPD7910 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD8131 Suspended
0.7016 Intermediate Similarity NPD1809 Phase 2
0.7015 Intermediate Similarity NPD2629 Approved
0.7015 Intermediate Similarity NPD5951 Approved
0.7014 Intermediate Similarity NPD6798 Discontinued
0.7007 Intermediate Similarity NPD5585 Approved
0.7007 Intermediate Similarity NPD3025 Approved
0.7007 Intermediate Similarity NPD3024 Approved
0.7 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD1358 Approved
0.7 Intermediate Similarity NPD2342 Discontinued
0.6993 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6992 Remote Similarity NPD6858 Approved
0.6992 Remote Similarity NPD7094 Approved
0.6986 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6986 Remote Similarity NPD5124 Phase 1
0.6978 Remote Similarity NPD1281 Approved
0.6978 Remote Similarity NPD5351 Clinical (unspecified phase)
0.6978 Remote Similarity NPD5350 Clinical (unspecified phase)
0.6968 Remote Similarity NPD7239 Suspended
0.6963 Remote Similarity NPD7157 Approved
0.696 Remote Similarity NPD288 Approved
0.6959 Remote Similarity NPD2799 Discontinued
0.6959 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6957 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6957 Remote Similarity NPD1778 Approved
0.6954 Remote Similarity NPD4110 Phase 3
0.6954 Remote Similarity NPD3750 Approved
0.6954 Remote Similarity NPD4109 Clinical (unspecified phase)
0.695 Remote Similarity NPD8651 Approved
0.694 Remote Similarity NPD7159 Clinical (unspecified phase)
0.6933 Remote Similarity NPD7037 Approved
0.6929 Remote Similarity NPD289 Clinical (unspecified phase)
0.6918 Remote Similarity NPD2979 Phase 3
0.6918 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6917 Remote Similarity NPD6124 Clinical (unspecified phase)
0.6897 Remote Similarity NPD3268 Approved
0.6894 Remote Similarity NPD4750 Phase 3
0.6884 Remote Similarity NPD4093 Discontinued
0.688 Remote Similarity NPD844 Approved
0.6875 Remote Similarity NPD2606 Approved
0.6875 Remote Similarity NPD2605 Approved
0.6864 Remote Similarity NPD8313 Approved
0.6864 Remote Similarity NPD8312 Approved
0.6857 Remote Similarity NPD1610 Phase 2
0.6857 Remote Similarity NPD422 Phase 1
0.6857 Remote Similarity NPD1201 Approved
0.6855 Remote Similarity NPD845 Approved
0.6855 Remote Similarity NPD7819 Suspended
0.6853 Remote Similarity NPD6584 Phase 3
0.6846 Remote Similarity NPD3299 Clinical (unspecified phase)
0.6838 Remote Similarity NPD6671 Approved
0.6835 Remote Similarity NPD1751 Approved
0.6828 Remote Similarity NPD5155 Approved
0.6828 Remote Similarity NPD5156 Approved
0.6818 Remote Similarity NPD7041 Phase 2
0.6818 Remote Similarity NPD7040 Clinical (unspecified phase)
0.6818 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6813 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6809 Remote Similarity NPD3972 Approved
0.68 Remote Similarity NPD6100 Approved
0.68 Remote Similarity NPD4477 Approved
0.68 Remote Similarity NPD4476 Approved
0.68 Remote Similarity NPD2438 Suspended
0.68 Remote Similarity NPD6099 Approved
0.6797 Remote Similarity NPD6190 Approved
0.6795 Remote Similarity NPD5699 Approved
0.6788 Remote Similarity NPD9493 Approved
0.6788 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6786 Remote Similarity NPD3847 Discontinued
0.6784 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6783 Remote Similarity NPD1470 Approved
0.6783 Remote Similarity NPD1164 Approved
0.6781 Remote Similarity NPD6812 Clinical (unspecified phase)
0.6779 Remote Similarity NPD7119 Phase 2
0.6772 Remote Similarity NPD7028 Phase 2
0.6769 Remote Similarity NPD5909 Discontinued
0.6763 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6763 Remote Similarity NPD1651 Approved
0.6761 Remote Similarity NPD6583 Phase 3
0.6761 Remote Similarity NPD6582 Phase 2
0.6761 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6761 Remote Similarity NPD4359 Approved
0.6761 Remote Similarity NPD4749 Approved
0.6759 Remote Similarity NPD3594 Approved
0.6759 Remote Similarity NPD3595 Approved
0.6755 Remote Similarity NPD2346 Discontinued
0.6753 Remote Similarity NPD6666 Approved
0.6753 Remote Similarity NPD6667 Approved
0.675 Remote Similarity NPD8455 Phase 2
0.6744 Remote Similarity NPD8150 Discontinued
0.6741 Remote Similarity NPD7843 Approved
0.6738 Remote Similarity NPD1611 Approved
0.6736 Remote Similarity NPD2798 Approved
0.6735 Remote Similarity NPD6233 Phase 2
0.6735 Remote Similarity NPD7961 Discontinued
0.6731 Remote Similarity NPD7314 Clinical (unspecified phase)
0.673 Remote Similarity NPD6677 Suspended
0.6728 Remote Similarity NPD7833 Phase 2
0.6728 Remote Similarity NPD7831 Phase 2
0.6728 Remote Similarity NPD7832 Clinical (unspecified phase)
0.6714 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6714 Remote Similarity NPD2286 Discontinued
0.6713 Remote Similarity NPD6696 Suspended
0.6712 Remote Similarity NPD4625 Phase 3
0.6711 Remote Similarity NPD4534 Discontinued
0.671 Remote Similarity NPD7390 Discontinued
0.6707 Remote Similarity NPD7228 Approved
0.6692 Remote Similarity NPD6647 Phase 2
0.6692 Remote Similarity NPD2684 Approved
0.6691 Remote Similarity NPD2228 Approved
0.6691 Remote Similarity NPD5283 Phase 1
0.6691 Remote Similarity NPD2234 Approved
0.6691 Remote Similarity NPD1241 Discontinued
0.6691 Remote Similarity NPD1894 Discontinued
0.6691 Remote Similarity NPD2229 Approved
0.669 Remote Similarity NPD2230 Approved
0.669 Remote Similarity NPD3635 Approved
0.669 Remote Similarity NPD4208 Discontinued
0.669 Remote Similarity NPD2233 Approved
0.669 Remote Similarity NPD3636 Approved
0.669 Remote Similarity NPD3637 Approved
0.669 Remote Similarity NPD1608 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data